Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP982731priorityCriticalpatent/ECSP982731A/en
Publication of ECSP982731ApublicationCriticalpatent/ECSP982731A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Nuevos benzotiazoles y sales de los mismos, composiciones farmacéuticas que contienen tales compuestos y métodos para usar tales compuestos en el tratamiento de desórdenes asociados a la proteína tirosina cinasa tal como desórdenes inmunológicos.Novel benzothiazoles and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of disorders associated with protein tyrosine kinase such as immunological disorders.
ECSP9827311998-11-091998-11-09
BENZOTIAZOLE INHIBITORS OF PROTEIN THYROSINE KINASE
ECSP982731A
(en)
AN IMIDAZOQUINOXALINE COMPOUND, METHOD FOR THE TREATMENT OF A SUFFERING OR DISORDER ASSOCIATED WITH THE THYROSINAKINASE PROTEIN, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND METHODS FOR PREPARING SUCH COMPOUNDS AND THEIR INTERMEDIARIES
ENANTIOSELECTIVE PROCESS FOR THE PREPARATION OF BOTH ENANTIOMERS OF 10,11-DIHIDRO-10-HIDROXI-5H-DIBENZ- [b, f] -AZEPIN-5-CARBOXAMIDE AND ITS NEW GLASS FORMS